Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital Perspective.
Am J Cardiovasc Drugs
; 22(1): 93-104, 2022 Jan.
Article
in En
| MEDLINE
| ID: mdl-34331235
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adenosine Monophosphate
/
Purinergic P2Y Receptor Antagonists
/
Percutaneous Coronary Intervention
Type of study:
Clinical_trials
/
Etiology_studies
/
Health_economic_evaluation
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Am J Cardiovasc Drugs
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos